Liu Q - Search Results

1

Design, synthesis and biological evaluation of cinnamamide-quinazoline derivatives as potential EGFR inhibitors to reverse T790M mutation.

Zhang B, Xu Z, Liu Q, Xia S, Liu Z, Liao Z, Gou S. Zhang B, et al. Among authors: liu z, liu q. Bioorg Chem. 2021 Dec;117:105420. doi: 10.1016/j.bioorg.2021.105420. Epub 2021 Oct 12. Bioorg Chem. 2021. PMID: 34655841

2

Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with "lock-in" function.

Zhao Y, Qu B, Wu X, Li X, Liu Q, Jin X, Guo L, Hai L, Wu Y. Zhao Y, et al. Among authors: liu q. Eur J Med Chem. 2014 Jul 23;82:314-23. doi: 10.1016/j.ejmech.2014.05.072. Epub 2014 Jun 2. Eur J Med Chem. 2014. PMID: 24927052

3

Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.

Liu QQ, Lu K, Zhu HM, Kong SL, Yuan JM, Zhang GH, Chen NY, Gu CX, Pan CX, Mo DL, Su GF. Liu QQ, et al. Eur J Med Chem. 2019 Mar 1;165:293-308. doi: 10.1016/j.ejmech.2019.01.004. Epub 2019 Jan 11. Eur J Med Chem. 2019. PMID: 30685528

4

The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma.

Liu Q, Hua S, Wang X, Chen F, Gou S. Liu Q, et al. Cancer Immunol Immunother. 2021 Feb;70(2):497-508. doi: 10.1007/s00262-020-02697-3. Epub 2020 Aug 25. Cancer Immunol Immunother. 2021. PMID: 32840656 Free PMC article.

5

Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.

Liu Q, Liu Z, Hua W, Gou S. Liu Q, et al. Among authors: liu z. J Med Chem. 2021 Feb 11;64(3):1701-1712. doi: 10.1021/acs.jmedchem.0c02048. Epub 2021 Feb 2. J Med Chem. 2021. PMID: 33529017

6

Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors.

Zhang B, Liu Z, Xia S, Liu Q, Gou S. Zhang B, et al. Among authors: liu z, liu q. Eur J Med Chem. 2021 Apr 15;216:113300. doi: 10.1016/j.ejmech.2021.113300. Epub 2021 Feb 20. Eur J Med Chem. 2021. PMID: 33640672

7

Blood-Brain Barrier Permeable and NO-Releasing Multifunctional Nanoparticles for Alzheimer's Disease Treatment: Targeting NO/cGMP/CREB Signaling Pathways.

Liu Z, Liu Q, Zhang B, Liu Q, Fang L, Gou S. Liu Z, et al. Among authors: liu q. J Med Chem. 2021 Sep 23;64(18):13853-13872. doi: 10.1021/acs.jmedchem.1c01240. Epub 2021 Sep 13. J Med Chem. 2021. PMID: 34517696

8

Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway.

Liu Q, Zhang B, Wang Y, Wang X, Gou S. Liu Q, et al. Eur J Med Chem. 2022 Feb 5;229:114058. doi: 10.1016/j.ejmech.2021.114058. Epub 2021 Dec 17. Eur J Med Chem. 2022. PMID: 34954595

9

Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework.

Yang Y, Liu Q, Wang X, Gou S. Yang Y, et al. Among authors: liu q. Bioorg Med Chem Lett. 2023 May 15;88:129305. doi: 10.1016/j.bmcl.2023.129305. Epub 2023 Apr 26. Bioorg Med Chem Lett. 2023. PMID: 37116762

10

Comparative study on composition, physicochemical and antioxidant characteristics of different varieties of kiwifruit seed oil in China.

Deng J, Liu Q, Zhang Q, Zhang C, Liu D, Fan D, Yang H. Deng J, et al. Among authors: liu q, liu d. Food Chem. 2018 Oct 30;264:411-418. doi: 10.1016/j.foodchem.2018.05.063. Epub 2018 May 15. Food Chem. 2018. PMID: 29853395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,389 results

Search Page

Filters